BREAKING: Trump's FDA Commissioner Resigns

The Bulwark's live episode breaks down the sudden departure of FDA Commissioner Marty McCary from the Trump administration, a move described as either a resignation or firing amid intense political and policy pressures. McCary, a respected surgeon and academic with a background in medical errors, was appointed to lead the FDA as part of Robert F. Kennedy Jr.'s broader effort to reshape HHS with a cohort of politically aligned, often contrarian health figures. While initially seen as a credible, serious appointee, McCary became embroiled in multiple high-stakes controversies, including delays in reviewing the abortion pill mifepristone, pressure to loosen vaping regulations despite scientific concerns, and allegations of suppressing peer-reviewed research on vaccine safety. These tensions placed him at odds with both the White House, which favored industry-friendly policies, and conservative pro-life groups demanding stricter abortion drug controls. The episode highlights how McCary’s role became a lightning rod in the broader ideological struggle within the administration over public health authority, regulatory independence, and the politicization of science. The host and guest conclude that McCary’s exit reflects deeper instability in the Trump administration’s health policy apparatus and signals growing friction between political agendas and institutional integrity at federal agencies. Key takeaways include: 1) The FDA is now a political battleground where scientific independence is increasingly compromised by partisan agendas; 2) The abortion pill mifepristone has become a flashpoint in the culture war, with the administration avoiding decisive action; 3) Appointing credible experts does not insulate them from political pressure when their decisions conflict with presidential or ideological priorities; 4) The White House’s inconsistent messaging on health issues undermines public trust in federal agencies; 5) The departure of McCary underscores the fragility of institutional leadership in a politicized executive branch.